NCT05673928 2026-01-21A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)M.D. Anderson Cancer CenterPhase 2 Recruiting30 enrolled